百洋医药
(301015)
| 流通市值：98.28亿 | | | 总市值：98.29亿 |
| 流通股本：5.26亿 | | | 总股本：5.26亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,765,302,461.03 | 1,467,403,220.46 | 1,270,692,224.3 | 1,898,964,855.13 |
| 应收票据及应收账款 | 1,894,352,245.23 | 2,000,514,331.8 | 2,290,877,265.52 | 2,147,426,658.88 |
| 其中：应收票据 | 110,790,124.93 | 115,977,020.31 | 101,893,274.04 | 137,500,781 |
| 应收账款 | 1,783,562,120.3 | 1,884,537,311.49 | 2,188,983,991.48 | 2,009,925,877.88 |
| 应收款项融资 | 178,127,439.06 | 215,387,955.19 | 382,024,955.95 | 207,415,523.13 |
| 预付款项 | 236,468,278.91 | 211,416,570.55 | 279,648,318.11 | 202,623,864.01 |
| 其他应收款合计 | 141,955,570.98 | 161,577,496.67 | 53,217,503 | 35,602,928.21 |
| 其中:应收利息 | - | - | 3,031,330.64 | - |
| 存货 | 830,608,535.62 | 927,753,115.69 | 880,266,749.49 | 613,658,864.75 |
| 其他流动资产 | 68,831,307.71 | 81,932,896.21 | 30,812,343.42 | 17,686,251.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,216,481,448.14 | 5,110,975,480.5 | 5,370,923,485.57 | 5,148,586,920.69 |
| 非流动资产: | | | | |
| 长期股权投资 | 815,362,181.6 | 727,624,417.04 | 323,496,875.76 | 281,811,534.46 |
| 其他权益工具投资 | - | - | 39,350,514.4 | 24,420,171.44 |
| 其他非流动金融资产 | 15,000,000 | 15,000,000 | - | - |
| 投资性房地产 | 1,303,080.34 | 1,327,708.18 | 1,352,336.02 | 1,376,963.86 |
| 固定资产 | 522,548,314.18 | 535,910,126.42 | 465,668,502.19 | 211,241,912.61 |
| 在建工程 | 167,808,761.65 | 152,262,124.97 | 219,368,083.05 | 105,692,353.02 |
| 使用权资产 | 117,122,219.84 | 122,481,520.03 | 126,429,603.91 | 102,106,430.99 |
| 无形资产 | 222,226,566.48 | 227,589,941.5 | 138,536,754.08 | 98,361,333.95 |
| 商誉 | 112,486,286.52 | 112,486,286.52 | 107,595,282.21 | 694,759.16 |
| 长期待摊费用 | 39,572,658.55 | 40,728,872.05 | 35,989,909.93 | 32,059,912.44 |
| 递延所得税资产 | 69,103,359.12 | 58,098,495.88 | 63,350,040.89 | 48,893,177.22 |
| 其他非流动资产 | 3,883,031.3 | 8,099,278.04 | 4,326,772.03 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,086,416,459.58 | 2,001,608,770.63 | 1,525,464,674.47 | 906,658,549.15 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,302,897,907.72 | 7,112,584,251.13 | 6,896,388,160.04 | 6,055,245,469.84 |
| 流动负债: | | | | |
| 短期借款 | 1,278,356,091.24 | 1,098,574,415.39 | 958,279,440.09 | 1,330,423,317.43 |
| 应付票据及应付账款 | 1,116,040,168.81 | 1,162,508,094.45 | 1,252,203,920.74 | 906,306,816.27 |
| 其中：应付票据 | 354,038,998.18 | 397,938,509.16 | 407,387,980.76 | 301,237,522.05 |
| 应付账款 | 762,001,170.63 | 764,569,585.29 | 844,815,939.98 | 605,069,294.22 |
| 合同负债 | 109,124,551.45 | 118,522,639.79 | 80,923,112.4 | 82,137,814.65 |
| 应付职工薪酬 | 62,673,053.92 | 108,749,922.84 | 81,945,808.36 | 70,185,729.77 |
| 应交税费 | 106,041,568.1 | 108,476,627.99 | 162,858,721.38 | 103,871,273.7 |
| 其他应付款合计 | 583,942,172.69 | 560,404,147.45 | 510,704,135.02 | 59,890,910.76 |
| 一年内到期的非流动负债 | 72,502,886.51 | 71,279,847.56 | 58,769,604.16 | 19,293,175.66 |
| 其他流动负债 | 25,896,492.69 | 29,447,918.17 | 29,538,659.14 | 19,595,157.9 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,354,576,985.41 | 3,257,963,613.64 | 3,135,223,401.29 | 2,591,704,196.14 |
| 非流动负债: | | | | |
| 长期借款 | 352,609,882.84 | 357,772,882.84 | 342,808,143.84 | - |
| 应付债券 | 761,825,943.69 | 754,790,886.78 | 747,733,808.64 | 740,541,125.15 |
| 租赁负债 | 103,054,006.67 | 102,562,856.59 | 109,427,262.49 | 91,726,451.87 |
| 预计负债 | - | 5,000,000 | - | - |
| 递延收益 | 11,060,877.95 | 11,434,936.36 | 11,997,876.34 | - |
| 递延所得税负债 | 5,827,680.72 | 18,387,469.29 | 33,999,079.8 | 24,558,196.33 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,234,378,391.87 | 1,249,949,031.86 | 1,245,966,171.11 | 856,825,773.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,588,955,377.28 | 4,507,912,645.5 | 4,381,189,572.4 | 3,448,529,969.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 525,619,310 | 525,619,310 | 525,613,491 | 525,613,491 |
| 其他权益工具 | 99,752,556.35 | 99,752,556.35 | 99,770,477.85 | 99,770,477.85 |
| 资本公积 | -2,523,778.82 | -2,523,778.82 | - | 421,740,314.04 |
| 其他综合收益 | 2,248,336.85 | 1,678,152.03 | 309,080.68 | 685,941.31 |
| 盈余公积 | 202,078,158.26 | 202,078,158.26 | 109,043,672.76 | 170,563,287.6 |
| 未分配利润 | 1,633,318,820.14 | 1,548,306,006.77 | 1,575,621,431.7 | 1,417,143,880.71 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,460,493,402.78 | 2,374,910,404.59 | 2,310,358,153.99 | 2,635,517,392.51 |
| 少数股东权益 | 253,449,127.66 | 229,761,201.04 | 204,840,433.65 | -28,801,892.16 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,713,942,530.44 | 2,604,671,605.63 | 2,515,198,587.64 | 2,606,715,500.35 |
| 负债和股东权益合计 | 7,302,897,907.72 | 7,112,584,251.13 | 6,896,388,160.04 | 6,055,245,469.84 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-26 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |